Hurricane Helene, Donald Trump and a swelling population were intriguing North Carolina storylines in 2024 as The Center Square delivered news and information.
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costs—often exceeding $1,000 per month—put them out of reach for many Americans whose ...